Page
2 pages Search
Tag(s):
FTC claims Boehringer failed to answer subpoena
Premium Article - Wednesday, 28 October 2009
The US Federal Trade Commission says that German drugmaker Boehringer Ingelheim has refused to respond to subpoenas sent as part of an investigation of whether the company violated section 5 of the FTC Act when it paid a rival to end patent litigation.
Senate committee approves restrictions on generic drug settlements
Premium Article - Friday, 16 October 2009
The Judiciary Committee of the US Senate yesterday approved a bill that would restrict “reverse payment settlements” between drug manufacturers, making most illegal under the country’s antitrust laws.
MDL panel sends Androgel cases to Georgia
Premium Article - Wednesday, 07 October 2009
Eight antitrust lawsuits accusing four US pharmaceutical companies of conspiring to delay the entrance of a generic testosterone replacement drug have been consolidated in a Georgia federal court.
California approves pay-for-delay in Cipro case
Premium Article - Thursday, 27 August 2009
A California state court has granted pharmaceutical company Bayer’s motion to dismiss an antitrust claim by indirect purchasers of its branded antibiotic Cipro.
Search GCR
Register for Free GCR Daily News
GCR April/May 2012
In this issue:
Survey: Australia • Howrey: in their words • Rod Sims interview • GCR cartel roundtable • GCR Live Law Leaders Asia-Pacific
GCR Live Events
Jun
20
GCR Live Financial Services and Competition Law 2012
Organiser: Global Competition Review
Wed, 20th June
London, United Kingdom
Jun
28
GCR Live Consumer Goods and Retail - Latin America 2012
Organiser: Global Competition Review
Thu, 28th June
São Paulo, Brasil
Oct
09
Nov
13
GCR Live 4th Annual Competition Law Review
Organiser: Global Competition Review
Tue, 13th November - Wed, 14th November
Brussels, Belgium
Feb
08
